Unmet Quality Needs in Oral Drug Delivery: Contrasts of Drug Content and Uniformity on Distinct Approaches for Achieving Individual Dosing
- 26 Downloads
Individualized dosing is often required in pharmacotherapy, particularly for pediatric and geriatric patients and adjustment of drugs that demand dose adaptation. This study aimed to evaluate critical quality attributes (CQAs) of doses obtained by distinct approaches for achieving individual dosing. Approaches were evaluated as follows: subdivision of tablets by splitter and hand (haloperidol) and delivery by plastic dropper bottle (haloperidol), glass dropper bottle (clonazepam), dosing cup (sodium valproate), and dosing syringe (carbamazepine), including brand name, generic, and similar marketed products. Measuring devices were packaged with their respective product. Drug content uniformity was assessed to each substance according to pharmacopeial methods. Tablets subdivided by splitter had the poorest performance among all approaches, in which doses ranged around 60% of the labeled amount (Acceptance Value = 58.1 and RSD = 23.2%). The greatest performances were observed for the dosing syringe which fulfilled all the requirements for dose precision and for the glass dropper bottle. There were significant differences in dose delivery between manufacturers of the same medicine when measuring the same volume or number of drops. High drug content variability is extremely harmful to pharmacotherapy and may result in therapeutic failure or toxicity. It is crucial that measuring devices and scoring of tablets be checked for functionality and standardized for different manufacturers of the same medicine. Part of the approaches for achieving individual dosing did not meet the quality needs for drug content and uniformity. Yet, our findings show that more accurate and precise dosing can be accessed when using the dosing syringe and glass dropper bottle.
KEY WORDSindividualized medicines oral drug delivery quality control
- 1.Mehuys E, Dupond L, Petrovic M, Christiaens T, Van Bortel L, Adriaens E, et al. Medication management among home-dwelling older patients with chronic diseases: possible roles for community pharmacists. J Nutr Health Aging. 2012;16(8):721–6. https://doi.org/10.1007/s12603-012-0028-x.CrossRefPubMedGoogle Scholar
- 11.Hurst M. Oral medication dispensers in clinical research. J Clin Res Best Pract. 2006;2(9):1–3.Google Scholar
- 13.Ph. Eur. 2.9.27. Uniformity of mass of delivered doses from multidose containers. In: Council of Europe, editor, 8th ed. Strasbourg, France; 2014.Google Scholar
- 14.Suárez-González J, Santoveña-Estévez A, Armijo-Ruíz S, Castillo A, Fariña JB. A high-demanding strategy to ensure the highest quality standards of oral liquid individualized medicines for pediatric use. AAPS PharmSciTech. 2019;20(5):208–11. https://doi.org/10.1208/s12249-019-1432-x.CrossRefPubMedGoogle Scholar
- 15.Brazilian Pharmacopoeia. Brazilian Pharmacopoeia. 5th ed. Brazil: Brasilia; 2010.Google Scholar
- 16.United States Pharmacopeia (USP). The United States Pharmacopoeia 39—the National Formulary 34, 39th ed. Baltimore, United States; 2016.Google Scholar
- 19.Food and Drug Administration. Guidance for industry tablet scoring: nomenclature, labeling, and data for evaluation. 2013. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM269921.pdf. Accessed 28 Apr 2019.
- 20.United States Pharmacopeia (USP). <1221> Teaspoon. The United States Pharmacopoeia 29—the National Formulary 24, 29th ed. Rockville, United States; 2006.Google Scholar
- 22.United States Pharmacopeia (USP). The United States Pharmacopoeia 27—the National Formulary 22, 27th ed. Baltimore, United States; 2004.Google Scholar
- 25.Eserian JK, Lombardo M. Potential dose adjustment implications resulting from clonazepam tablet splitting. Saúde (Santa Maria). 2017;43(3):1–7.Google Scholar
- 27.van Riet-Nales DA, Doeve ME, Nicia AE, Teerenstra S, Notenboom K, Hekster YA, et al. The accuracy, precision and sustainability of different techniques for tablet subdivision: breaking by hand and the use of tablet splitters or a kitchen knife. Int J Pharm. 2014;466(1–2):44–51. https://doi.org/10.1016/j.ijpharm.2014.02.031.CrossRefPubMedGoogle Scholar
- 30.Food and Drug Administration. CFR - Code of Federal Regulations Title 21. 2018. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=210.3. Accessed 16 Mar 2019.